DigestRedComo funciona
Red
/
Empresas
Ba
No verificado

Bayer

Sobre qué escribimos

BiotecnologíaFarmacéuticaIndustriaMedicina - VariosSalud

173 Comunicados de prensa

Ver todos los comunicados de prensa
17/09/2026
Robigo and Leaps by Bayer Announce Series A Financing to Advance Engineered Biologicals That Protect Yields and Reduce Costs
Fuente
Bayer
Editor
Business Wire
1.00
0
17/09/2026
Biotecnología
Higiene alimentaria
Sanidad
Salud
Farmacéutica
Ciencia
Medicina - Varios
Industria
Bayer’s KERENDIA® (finerenone) Receives FDA Approval as the First New Treatment in 30 Years for Adults with Chronic Kidney Disease (CKD) and Type 1 Diabetes
Fuente
Bayer
Editor
Business Wire
1.00
0
10/09/2026
Bayer Launches Nationwide Science Delivers Tour to Take Science on the Road
Fuente
Bayer
Editor
Business Wire
1.00
0
10/09/2026
Industria
Oncología
Salud
Higiene alimentaria
Sanidad
Medicina - Varios
Farmacéutica
Biotecnología
U.S. FDA Grants Accelerated Approval to Bayer’s HYRNUO® (sevabertinib) as a First-Line Targeted Therapy for Patients with HER2-Mutated Non-Small Cell Lung Cancer
Fuente
Bayer
Editor
Business Wire
1.00
0
09/09/2026
Mercado laboral
Industria
Energias renovables
Energía
Agricultura
Materias primas
Bayer and Neste Close Commercial Agreement to Jointly Scale newgold® Winter Canola for Biofuels Production
Fuente
Bayer
Editor
Business Wire
1.00
0
09/09/2026
Industria
Salud
Medicina - Varios
Ciencia
Farmacéutica
Cardiología
Biotecnología
BAYER INITIATES PHASE II STUDY OF INVESTIGATIONAL GIRK4 INHIBITOR IN PATIENTS WITH ATRIAL FIBRILLATION
Fuente
Bayer
Editor
Business Wire
1.00
0
02/09/2026
Industria
Técnica
Agricultura
Materias primas
Ciencia
Bayer Advances Combined Seed and Crop Protection Pipeline and Enters Phase of Blockbuster Launches
Fuente
Bayer
Editor
Business Wire
1.00
0
30/08/2026
Eventos
Industria
Ciencia
Cardiología
Medicina nuclear
Biotecnología
Farmacéutica
Salud
Medicina - Varios
Bayer Announces Phase III REVEAL Study with Investigational PET Radiotracer Iodine 124 Evuzamitide Presented as Late-Breaker at ESC 2026
Fuente
Bayer
Editor
Business Wire
1.00
0
20/08/2026
Eventos
Industria
Ciencia
Cardiología
Biotecnología
Farmacéutica
Salud
Medicina - Varios
Bayer to Present New Phase III Data from Its Cardiovascular, Kidney, and Stroke Clinical Trial Programs at ESC 2026
Fuente
Bayer
Editor
Business Wire
1.00
0
28/07/2026
Multimedia
Industria
Venta al público/Minorista
Fitness
Sanidad
Salud
Ir de compras
Farmacéutica
One A Day® Introduces New Women's Multi Gummy Formula with 1,000 mcg Biotin
Fuente
Bayer
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0